TreeWAS – Variant ID: rs150611042

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.972	0.028
N41 Inflammatory diseases of prostate	0.000	0.975	0.025
H52.1 Myopia	0.025	0.975	0.000
N41.1 Chronic prostatitis	0.000	0.976	0.024
H52 Disorders of refraction and accommodation	0.022	0.978	0.000
H52.3 Anisometropia and aniseikonia	0.021	0.979	0.000
N43.3 Hydrocele, unspecified	0.000	0.980	0.020
N43 Hydrocele and spermatocele	0.000	0.981	0.019
N41.8 Other inflammatory diseases of prostate	0.000	0.982	0.018
N41.3 Prostatocystitis	0.000	0.982	0.018
N41.2 Abscess of prostate	0.000	0.982	0.018
N40-N51 Diseases of male genital organs	0.000	0.982	0.018
H52.2 Astigmatism	0.018	0.982	0.000
D50.9 Iron deficiency anaemia, unspecified	0.000	0.982	0.018
N42 Other disorders of prostate	0.000	0.982	0.018
N42.9 Disorder of prostate, unspecified	0.000	0.983	0.017
H52.7 Disorder of refraction, unspecified	0.016	0.984	0.000
H52.6 Other disorders of refraction	0.016	0.984	0.000
H52.5 Disorders of accommodation	0.016	0.984	0.000
H52.4 Presbyopia	0.016	0.984	0.000
H52.0 Hypermetropia	0.016	0.984	0.000
N50 Other disorders of male genital organs	0.000	0.985	0.015
N45 Orchitis and epididymitis	0.000	0.985	0.015
N50.8 Other specified disorders of male genital organs	0.000	0.986	0.014
N42.8 Other specified disorders of prostate	0.000	0.986	0.014
N41.0 Acute prostatitis	0.000	0.986	0.014
N43.2 Other hydrocele	0.000	0.986	0.013
N43.1 Infected hydrocele	0.000	0.986	0.013
N43.0 Encysted hydrocele	0.000	0.986	0.013
G56.0 Carpal tunnel syndrome	0.000	0.987	0.013
N42.0 Calculus of prostate	0.000	0.987	0.013
N51 Disorders of male genital organs in diseases classified elsewhere	0.000	0.987	0.013
N46 Male infertility	0.000	0.987	0.013
N44 Torsion of testis	0.000	0.987	0.013
N42.3 Dysplasia of prostate	0.000	0.987	0.013
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.000	0.987	0.013
N50.9 Disorder of male genital organs, unspecified	0.000	0.987	0.012
N42.2 Atrophy of prostate	0.000	0.987	0.012
N42.1 Congestion and haemorrhage of prostate	0.000	0.988	0.012
N43.4 Spermatocele	0.000	0.989	0.011
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.000	0.989	0.011
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.000	0.989	0.011
R79.8 Other specified abnormal findings of blood chemistry	0.000	0.989	0.011
Y84.8 Other medical procedures	0.011	0.989	0.000
Y84.6 Urinary catheterisation	0.011	0.989	0.000
N48 Other disorders of penis	0.000	0.990	0.010
N51.8 Other disorders of male genital organs in diseases classified elsewhere	0.000	0.990	0.010
N51.2 Balanitis in diseases classified elsewhere	0.000	0.990	0.010
N51.1 Disorders of testis and epididymis in diseases classified elsewhere	0.000	0.990	0.010
N51.0 Disorders of prostate in diseases classified elsewhere	0.000	0.990	0.010
N50.0 Atrophy of testis	0.000	0.990	0.009
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.009	0.991	0.000
N50.1 Vascular disorders of male genital organs	0.000	0.991	0.008
D50 Iron deficiency anaemia	0.000	0.992	0.008
N48.0 Leukoplakia of penis	0.000	0.992	0.008
N49.9 Inflammatory disorder of unspecified male genital organ	0.000	0.992	0.008
N49.8 Inflammatory disorders of other specified male genital organs	0.000	0.992	0.008
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens	0.000	0.992	0.008
N49.0 Inflammatory disorders of seminal vesicle	0.000	0.992	0.008
N48.8 Other specified disorders of penis	0.000	0.992	0.008
O16 Unspecified maternal hypertension	0.000	0.992	0.008
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.007	0.993	0.000
N48.5 Ulcer of penis	0.000	0.993	0.007
N48.3 Priapism	0.000	0.993	0.007
N48.9 Disorder of penis, unspecified	0.000	0.993	0.007
D50.8 Other iron deficiency anaemias	0.000	0.993	0.007
N48.1 Balanoposthitis	0.000	0.993	0.007
N48.6 Balanitis xerotica obliterans	0.000	0.993	0.007
Y84.1 Kidney dialysis	0.007	0.993	0.000
E83.4 Disorders of magnesium metabolism	0.007	0.993	0.000
Y84.9 Medical procedure, unspecified	0.006	0.993	0.000
Y84.7 Blood-sampling	0.006	0.993	0.000
Y84.5 Insertion of gastric or duodenal sound	0.006	0.993	0.000
Y84.3 Shock therapy	0.006	0.993	0.000
Y84.4 Aspiration of fluid	0.006	0.994	0.000
D50.1 Sideropenic dysphagia	0.000	0.994	0.006
L90.5 Scar conditions and fibrosis of skin	0.000	0.994	0.006
H49 Paralytic strabismus	0.006	0.994	0.000
N49.2 Inflammatory disorders of scrotum	0.000	0.994	0.006
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.994	0.006
H51 Other disorders of binocular movement	0.005	0.994	0.000
S92.30 Fracture of metatarsal bone (closed)	0.006	0.994	0.000
Z48.8 Other specified surgical follow-up care	0.006	0.994	0.000
N48.4 Impotence of organic origin	0.000	0.995	0.005
N48.2 Other inflammatory disorders of penis	0.000	0.995	0.005
H49.2 Sixth [abducent] nerve palsy	0.005	0.995	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.995	0.005
K35.0 Acute appendicitis with generalised peritonitis	0.000	0.995	0.005
F40.2 Specific (isolated) phobias	0.005	0.995	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.995	0.005
Z12.1 Special screening examination for neoplasm of intestinal tract	0.005	0.995	0.000
H49.0 Third [oculomotor] nerve palsy	0.005	0.995	0.000
L90 Atrophic disorders of skin	0.000	0.995	0.005
K13.0 Diseases of lips	0.005	0.995	0.000
S92.3 Fracture of metatarsal bone	0.005	0.995	0.000
R79 Other abnormal findings of blood chemistry	0.000	0.995	0.005
H49.9 Paralytic strabismus, unspecified	0.004	0.995	0.000
H49.8 Other paralytic strabismus	0.004	0.995	0.000
H49.4 Progressive external ophthalmoplegia	0.004	0.995	0.000
H49.3 Total (external) ophthalmoplegia	0.004	0.995	0.000
G56 Mononeuropathies of upper limb	0.000	0.995	0.005
H49.1 Fourth [trochlear] nerve palsy	0.004	0.996	0.000
H51.9 Disorder of binocular movement, unspecified	0.004	0.996	0.000
H51.8 Other specified disorders of binocular movement	0.004	0.996	0.000
H51.2 Internuclear ophthalmoplegia	0.004	0.996	0.000
H51.1 Convergence insufficiency and excess	0.004	0.996	0.000
H51.0 Palsy of conjugate gaze	0.004	0.996	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.004	0.996	0.000
S91.3 Open wound of other parts of foot	0.004	0.996	0.000
S91 Open wound of ankle and foot	0.004	0.996	0.000
Y84.2 Radiological procedure and radiotherapy	0.004	0.996	0.000
S92 Fracture of foot, except ankle	0.004	0.996	0.000
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.004	0.996	0.000
H50 Other strabismus	0.004	0.996	0.000
G56.1 Other lesions of median nerve	0.000	0.996	0.004
L90.9 Atrophic disorder of skin, unspecified	0.000	0.996	0.004
L90.8 Other atrophic disorders of skin	0.000	0.996	0.004
L90.6 Striae atrophicae	0.000	0.996	0.004
L90.4 Acrodermatitis chronica atrophicans	0.000	0.996	0.004
L90.3 Atrophoderma of Pasini and Pierini	0.000	0.996	0.004
L90.2 Anetoderma of Jadassohn-Pellizzari	0.000	0.996	0.004
L90.1 Anetoderma of Schweninger-Buzzi	0.000	0.996	0.004
K13 Other diseases of lip and oral mucosa	0.004	0.996	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.000	0.996	0.004
S90-S99 Injuries to the ankle and foot	0.004	0.996	0.000
S92.31 Fracture of metatarsal bone (open)	0.003	0.996	0.000
G56.2 Lesion of ulnar nerve	0.000	0.996	0.004
G56.9 Mononeuropathy of upper limb, unspecified	0.000	0.996	0.003
G56.4 Causalgia	0.000	0.996	0.003
S91.1 Open wound of toe(s) without damage to nail	0.004	0.996	0.000
Y84.0 Cardiac catheterisation	0.003	0.996	0.000
R79.0 Abnormal level of blood mineral	0.000	0.996	0.003
S96 Injury of muscle and tendon at ankle and foot level	0.003	0.997	0.000
S92.2 Fracture of other tarsal bone(s)	0.003	0.997	0.000
S91.0 Open wound of ankle	0.003	0.997	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.000	0.997	0.003
Z48 Other surgical follow-up care	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
O02.1 Missed abortion	0.000	0.997	0.003
S91.7 Multiple open wounds of ankle and foot	0.003	0.997	0.000
S91.2 Open wound of toe(s) with damage to nail	0.003	0.997	0.000
S92.4 Fracture of great toe	0.003	0.997	0.000
Z48.9 Surgical follow-up care, unspecified	0.003	0.997	0.000
S92.9 Fracture of foot, unspecified	0.003	0.997	0.000
S92.7 Multiple fractures of foot	0.003	0.997	0.000
S92.5 Fracture of other toe	0.003	0.997	0.000
S99 Other and unspecified injuries of ankle and foot	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
S92.1 Fracture of talus	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
S96.1 Injury of muscle and tendon of long extensor muscle of toe at ankle and foot level	0.003	0.997	0.000
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.003	0.997	0.000
G56.8 Other mononeuropathies of upper limb	0.000	0.997	0.003
J32.9 Chronic sinusitis, unspecified	0.000	0.997	0.003
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.000	0.997	0.003
G56.3 Lesion of radial nerve	0.000	0.997	0.003
H50.0 Convergent concomitant strabismus	0.003	0.997	0.000
H50.8 Other specified strabismus	0.003	0.997	0.000
H50.6 Mechanical strabismus	0.003	0.997	0.000
H50.5 Heterophoria	0.003	0.997	0.000
H50.4 Other and unspecified heterotropia	0.003	0.997	0.000
H50.3 Intermittent heterotropia	0.003	0.997	0.000
H50.2 Vertical strabismus	0.003	0.997	0.000
Y54.5 Other diuretics	0.003	0.997	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.003	0.997	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.003	0.997	0.000
S96.9 Injury of unspecified muscle and tendon at ankle and foot level	0.003	0.997	0.000
K13.2 Leukoplakia and other disturbances of oral epithelium, including tongue	0.003	0.997	0.000
K13.5 Oral submucous fibrosis	0.003	0.997	0.000
K13.3 Hairy leukoplakia	0.003	0.997	0.000
K13.1 Cheek and lip biting	0.003	0.997	0.000
S98 Traumatic amputation of ankle and foot	0.003	0.997	0.000
S97 Crushing injury of ankle and foot	0.003	0.997	0.000
S95 Injury of blood vessels at ankle and foot level	0.003	0.997	0.000
S94 Injury of nerves at ankle and foot level	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
V10-V19 Pedal cyclist injured in transport accident	0.003	0.997	0.000
J18.1 Lobar pneumonia, unspecified	0.003	0.997	0.000
K13.6 Irritative hyperplasia of oral mucosa	0.003	0.997	0.000
K13.4 Granuloma and granuloma-like lesions of oral mucosa	0.003	0.997	0.000
V98-V99 Other and unspecified transport accidents	0.003	0.997	0.000
N17.9 Acute renal failure, unspecified	0.003	0.997	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.003	0.997	0.000
S99.9 Unspecified injury of ankle and foot	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
S93.0 Dislocation of ankle joint	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.003	0.997	0.000
S96.8 Injury of other muscles and tendons at ankle and foot level	0.003	0.997	0.000
S96.7 Injury of multiple muscles and tendons at ankle and foot level	0.003	0.997	0.000
S96.2 Injury of intrinsic muscle and tendon at ankle and foot level	0.003	0.997	0.000
S96.0 Injury of muscle and tendon of long flexor muscle of toe at ankle and foot level	0.003	0.997	0.000
W49.9 Unspecified place	0.003	0.997	0.000
X20-X29 Contact with venomous animals and plants	0.003	0.997	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.002	0.997	0.000
X10-X19 Contact with heat and hot substances	0.003	0.997	0.000
S92.41 Fracture of great toe (open)	0.002	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.003	0.997	0.000
S01.2 Open wound of nose	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
W20-W49 Exposure to inanimate mechanical forces	0.003	0.997	0.000
V20-V29 Motorcycle rider injured in transport accident	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.003	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
H50.9 Strabismus, unspecified	0.002	0.997	0.000
F40 Phobic anxiety disorders	0.003	0.997	0.000
Z94.8 Other transplanted organ and tissue status	0.003	0.997	0.000
V99 Unspecified transport accident	0.002	0.997	0.000
Y00-Y09 Assault	0.003	0.997	0.000
S92.0 Fracture of calcaneus	0.002	0.997	0.000
X59 Exposure to unspecified factor	0.002	0.997	0.000
V80-V89 Other land transport accidents	0.003	0.997	0.000
R60.9 Oedema, unspecified	0.003	0.997	0.000
S92.51 Fracture of other toe (open)	0.002	0.997	0.000
S92.50 Fracture of other toe (closed)	0.002	0.997	0.000
S92.71 Multiple fractures of foot (open)	0.002	0.997	0.000
S92.70 Multiple fractures of foot (closed)	0.002	0.997	0.000
S92.91 Fracture of foot, unspecified (open)	0.002	0.997	0.000
S92.90 Fracture of foot, unspecified (closed)	0.002	0.997	0.000
S99.8 Other specified injuries of ankle and foot	0.002	0.997	0.000
S99.7 Multiple injuries of ankle and foot	0.002	0.997	0.000
Y35-Y36 Legal intervention and operations of war	0.002	0.997	0.000
Y10-Y34 Event of undetermined intent	0.002	0.997	0.000
X85-X99 Assault	0.002	0.997	0.000
X30-X39 Exposure to forces of nature	0.002	0.997	0.000
X00-X09 Exposure to smoke, fire and flames	0.002	0.997	0.000
W75-W84 Other accidental threats to breathing	0.002	0.997	0.000
W65-W74 Accidental drowning and submersion	0.002	0.997	0.000
V95-V97 Air and space transport accidents	0.002	0.997	0.000
V90-V94 Water transport accidents	0.002	0.997	0.000
V70-V79 Bus occupant injured in transport accident	0.002	0.997	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.002	0.997	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.002	0.997	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.002	0.997	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.997	0.000
S92.11 Fracture of talus (open)	0.002	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.997	0.000
Y54.7 Agents affecting calcification	0.002	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.997	0.000
Y54.0 Mineralocorticoids	0.002	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
S92.40 Fracture of great toe (closed)	0.002	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.997	0.000
Z48.0 Attention to surgical dressings and sutures	0.002	0.997	0.000
S90 Superficial injury of ankle and foot	0.002	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.002	0.997	0.000
S92.10 Fracture of talus (closed)	0.002	0.997	0.000
S93.4 Sprain and strain of ankle	0.002	0.997	0.000
S93.6 Sprain and strain of other and unspecified parts of foot	0.002	0.997	0.000
S93.5 Sprain and strain of toe(s)	0.002	0.997	0.000
S93.3 Dislocation of other and unspecified parts of foot	0.002	0.997	0.000
S93.2 Rupture of ligaments at ankle and foot level	0.002	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
O15 Eclampsia	0.000	0.998	0.002
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.000	0.998	0.002
V40-V49 Car occupant injured in transport accident	0.002	0.998	0.000
X59.3 Sports and athletics area	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.998	0.002
V18 Pedal cyclist injured in noncollision transport accident	0.002	0.998	0.000
V17 Pedal cyclist injured in collision with fixed or stationary object	0.002	0.998	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
X23 Contact with hornets, wasps and bees	0.002	0.998	0.000
H83.0 Labyrinthitis	0.002	0.998	0.000
M35.0 Sicca syndrome [Sjogren]	0.000	0.998	0.002
S93.1 Dislocation of toe(s)	0.002	0.998	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
J32.4 Chronic pansinusitis	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.000	0.998	0.002
K13.29 Other disturbances of oral epithelium, including tongue	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
S94.9 Injury of unspecified nerve at ankle and foot level	0.002	0.998	0.000
S94.8 Injury of other nerves at ankle and foot level	0.002	0.998	0.000
S94.7 Injury of multiple nerves at ankle and foot level	0.002	0.998	0.000
S94.3 Injury of cutaneous sensory nerve at ankle and foot level	0.002	0.998	0.000
S94.2 Injury of deep peroneal nerve at ankle and foot level	0.002	0.998	0.000
S94.1 Injury of medial plantar nerve	0.002	0.998	0.000
S94.0 Injury of lateral plantar nerve	0.002	0.998	0.000
S95.9 Injury of unspecified blood vessel at ankle and foot level	0.002	0.998	0.000
S95.8 Injury of other blood vessels at ankle and foot level	0.002	0.998	0.000
S95.7 Injury of multiple blood vessels at ankle and foot level	0.002	0.998	0.000
S95.2 Injury of dorsal vein of foot	0.002	0.998	0.000
S95.1 Injury of plantar artery of foot	0.002	0.998	0.000
S95.0 Injury of dorsal artery of foot	0.002	0.998	0.000
S97.8 Crushing injury of other parts of ankle and foot	0.002	0.998	0.000
S97.1 Crushing injury of toe(s)	0.002	0.998	0.000
S97.0 Crushing injury of ankle	0.002	0.998	0.000
S98.4 Traumatic amputation of foot, level unspecified	0.002	0.998	0.000
S98.3 Traumatic amputation of other parts of foot	0.002	0.998	0.000
S98.2 Traumatic amputation of two or more toes	0.002	0.998	0.000
S98.1 Traumatic amputation of one toe	0.002	0.998	0.000
S98.0 Traumatic amputation of foot at ankle level	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.000	0.998	0.002
W21 Striking against or struck by sports equipment	0.002	0.998	0.000
J32 Chronic sinusitis	0.000	0.998	0.002
Y65 Other misadventures during surgical and medical care	0.002	0.998	0.000
S82.40 Fracture of fibula alone (closed)	0.002	0.998	0.000
E83 Disorders of mineral metabolism	0.002	0.998	0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.002	0.998	0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V10 Pedal cyclist injured in collision with pedestrian or animal	0.002	0.998	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y60.0 During surgical operation	0.002	0.998	0.000
V98 Other specified transport accidents	0.002	0.998	0.000
X12 Contact with other hot fluids	0.002	0.998	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.002	0.998	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.002	0.998	0.000
Y64 Contaminated medical or biological substances	0.002	0.998	0.000
Y63 Failure in dosage during surgical and medical care	0.002	0.998	0.000
Y62 Failure of sterile precautions during surgical and medical care	0.002	0.998	0.000
Y61 Foreign object accidentally left in body during surgical and medical care	0.002	0.998	0.000
Y69 Unspecified misadventure during surgical and medical care	0.002	0.998	0.000
Y66 Nonadministration of surgical and medical care	0.002	0.998	0.000
V18.0 Driver injured in nontraffic accident	0.002	0.998	0.000
V28.2 Unspecified motorcycle rider injured in nontraffic accident	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
F40.0 Agoraphobia	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
W94 Exposure to high and low air pressure and changes in air pressure	0.002	0.998	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.002	0.998	0.000
X23.0 Home	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
W20 Struck by thrown, projected or falling object	0.002	0.998	0.000
X19 Contact with other and unspecified heat and hot substances	0.002	0.998	0.000
X18 Contact with other hot metals	0.002	0.998	0.000
X17 Contact with hot engines, machinery and tools	0.002	0.998	0.000
X16 Contact with hot heating appliances, radiators and pipes	0.002	0.998	0.000
X15 Contact with hot household appliances	0.002	0.998	0.000
X14 Contact with hot air and gases	0.002	0.998	0.000
X13 Contact with steam and hot vapours	0.002	0.998	0.000
X11 Contact with hot tap-water	0.002	0.998	0.000
X29 Contact with unspecified venomous animal or plant	0.002	0.998	0.000
X28 Contact with other specified venomous plants	0.002	0.998	0.000
X27 Contact with other specified venomous animals	0.002	0.998	0.000
X26 Contact with venomous marine animals and plants	0.002	0.998	0.000
X25 Contact with other specified venomous arthropods	0.002	0.998	0.000
X24 Contact with centipedes and venomous millipedes (tropical)	0.002	0.998	0.000
X22 Contact with scorpions	0.002	0.998	0.000
X21 Contact with venomous spiders	0.002	0.998	0.000
X20 Contact with venomous snakes and lizards	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.000	0.998	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.000	0.998	0.002
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.002	0.998	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
V29 Motorcycle rider injured in other and unspecified transport accidents	0.002	0.998	0.000
V27 Motorcycle rider injured in collision with fixed or stationary object	0.002	0.998	0.000
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.002	0.998	0.000
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.002	0.998	0.000
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V21 Motorcycle rider injured in collision with pedal cycle	0.002	0.998	0.000
V20 Motorcycle rider injured in collision with pedestrian or animal	0.002	0.998	0.000
W46 Contact with hypodermic needle	0.002	0.998	0.000
W45 Foreign body or object entering through skin	0.002	0.998	0.000
W43 Exposure to vibration	0.002	0.998	0.000
W42 Exposure to noise	0.002	0.998	0.000
W41 Exposure to high-pressure jet	0.002	0.998	0.000
W40 Explosion of other materials	0.002	0.998	0.000
W39 Discharge of firework	0.002	0.998	0.000
W38 Explosion and rupture of other specified pressurised devices	0.002	0.998	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.002	0.998	0.000
W36 Explosion and rupture of gas cylinder	0.002	0.998	0.000
W35 Explosion and rupture of boiler	0.002	0.998	0.000
W34 Discharge from other and unspecified firearms	0.002	0.998	0.000
W33 Rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
W32 Handgun discharge	0.002	0.998	0.000
W31 Contact with other and unspecified machinery	0.002	0.998	0.000
W30 Contact with agricultural machinery	0.002	0.998	0.000
W28 Contact with powered lawn mower	0.002	0.998	0.000
W27 Contact with nonpowered hand tool	0.002	0.998	0.000
W26 Contact with knife, sword or dagger	0.002	0.998	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.002	0.998	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.002	0.998	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.002	0.998	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.002	0.998	0.000
Y80 Physical medicine devices associated with adverse incidents	0.002	0.998	0.000
Y78 Radiological devices associated with adverse incidents	0.002	0.998	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.002	0.998	0.000
Y75 Neurological devices associated with adverse incidents	0.002	0.998	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.002	0.998	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.002	0.998	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.002	0.998	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.002	0.998	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.002	0.998	0.000
S82.20 Fracture of shaft of tibia (closed)	0.002	0.998	0.000
W49.8 Other specified place	0.002	0.998	0.000
W49.7 Farm	0.002	0.998	0.000
W49.6 Industrial and construction area	0.002	0.998	0.000
W49.5 Trade and service area	0.002	0.998	0.000
W49.4 Street and highway	0.002	0.998	0.000
W49.3 Sports and athletics area	0.002	0.998	0.000
W49.2 School, other institution and public administrative area	0.002	0.998	0.000
W49.1 Residential institution	0.002	0.998	0.000
X59.2 School, other institution and public administrative area	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
W22 Striking against or struck by other objects	0.002	0.998	0.000
W21.9 Unspecified place	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations